Evidence map›Paper›PMID 34452337›Full record

ArticleViruses2021

Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain).

Lesly Acosta, Nuria Soldevila, Nuria Torner, Ana Martínez, Xavier Ayneto, Cristina Rius, Mireia Jané, Angela Domínguez, The Influenza Surveillance Network Of Catalonia Pidirac

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lesly AcostaDepartment of Statistics and Operations Research, Polytechnic University of Catalonia/BARCELONATECH, 08028 Barcelona, Spain.
Nuria SoldevilaCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.ORCID 0000-0002-1353-5325
Nuria TornerCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.ORCID 0000-0003-0143-5295
Ana MartínezCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.
Xavier AynetoPublic Health Agency of Catalonia, 08005 Barcelona, Spain.
Cristina RiusCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.
Mireia JanéCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.
Angela DomínguezCIBER Epidemiología Salud Pública, CIBERESP, PREVICET Program, 28029 Madrid, Spain.ORCID 0000-0003-0219-1907
The Influenza Surveillance Network Of Catalonia Pidirac
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESUniversitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal influenza is a common cause of hospital admission, especially in older people and those with comorbidities. The objective of this study was to determine influenza vaccine effectiveness (VE) in preventing intensive care admissions and shortening the length of stay (LOS) in hospitalized laboratory-confirmed influenza cases (HLCI) in Catalonia (Spain). A retrospective cohort study was carried out during the 2017-2018 season in HLCI aged ≥18 years from 14 public hospitals. Differences in means and proportions were assessed using a t-test or a chi-square test as necessary and the differences were quantified using standardized effect measures: Cohen's d for quantitative and Cohen's w for categorical variables. Adjusted influenza vaccine effectiveness in preventing severity was estimated by multivariate logistic regression where the adjusted VE = (1 - adjusted odds ratio) · 100%; adjustment was also made using the propensity score. We analyzed 1414 HLCI aged ≥18 years; 465 (33%) were vaccinated, of whom 437 (94%) were aged ≥60 years, 269 (57.8%) were male and 295 (63.4%) were positive for influenza type B. ICU admission was required in 214 (15.1%) cases. There were 141/1118 (12.6%) ICU admissions in patients aged ≥60 years and 73/296 (24.7%) in those aged <60 years (

Indexed as

AdolescentAdultAgedFemaleHospitalizationHumansInfluenza, HumanInfluenza VaccinesLaboratoriesMaleMiddle AgedOrthomyxoviridaeRetrospective StudiesSeasonsSpainVaccinationInfluenza Vaccinesinfluenzaintensive care unitlength of stayvaccine effectiveness

Identifiers

PMID34452337
PMCPMC8402781
OpenAlexW3165249129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.